Formerly a National Institutes of Health senior investigator who studies and treats blood cancer, Christopher Hourigan has joined Virginia Tech to lead cancer research at the Fralin Biomedical Research Institute in Washington, D.C.
news, journals and articles from all over the world.
Formerly a National Institutes of Health senior investigator who studies and treats blood cancer, Christopher Hourigan has joined Virginia Tech to lead cancer research at the Fralin Biomedical Research Institute in Washington, D.C.